1. Willing and able to give written informed consent

2. Between the ages of 18 and 65 years (inclusive)

3. Fulfilled at least 4 ACR classification criteria

4. SLE patients with moderate, active disease

5. Subjects on stable dose of SLE medications for at least 4 weeks before randomization.

6. Women of child-bearing potential must practice a medically acceptable method of contraception..

7. Must understand the requirements of the study and agree to comply with the study protocol.

A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus